Eamonn Maher

Professor Eamonn Maher is the Dean of Aston Medical School at Aston University, within the College of Health and Life Sciences. His primary affiliation is with the School of Life & Health Sciences, where he leads research in genetic oncology and rare diseases. His work focuses on understanding the genetic basis of neoplasms, particularly in syndromes like von Hippel-Lindau disease, Birt-Hogg-Dubé syndrome, and hereditary renal cell carcinoma. He has published extensively on topics including genotype-specific cancer risk profiling, molecular diagnostics, and clinical guideline development.

Research Interests: Professor Maher's expertise spans cancer genetics, inherited predispositions to tumors, and the molecular mechanisms of genetic disorders. Key areas include:

• Neoplastic risk profiling in hereditary syndromes
• Genomic analysis of renal and endocrine tumors
• Clinical management of phaeochromocytoma/paraganglioma
• Imprinting disorders and epigenetic mechanisms
• Public health implications of rare kidney diseases

Recent Work Trends: His 2024–2025 publications emphasize:

• Advances in whole-genome sequencing for rare tumor diagnosis
• Systematic reviews of multiple primary renal tumors
• Guideline development for pediatric phaeochromocytoma/paraganglioma
• Genomic epidemiology of Birt-Hogg-Dubé syndrome

Collaborations: His international collaborations include studies on SDHx-deficient cancers, multi-locus imprinting disturbances, and the UK National Registry of Rare Kidney Diseases (RaDaR). He also contributes to initiatives like the ClinGen VHL Variant Curation Expert Panel and ERN GENTURIS.

Grants & Labs: While specific grants are not listed, his leadership in RaDaR and involvement in international registries indicate significant grant-funded research. His lab focuses on translational research bridging genetic discovery and clinical practice.